A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea)
Bionoxx Inc.
Bionoxx Inc.
Bionoxx Inc.
Roswell Park Cancer Institute
Imugene Limited
University of Chicago
University of Chicago
University of Chicago
Amsterdam UMC, location VUmc
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
Duke University
Dartmouth-Hitchcock Medical Center